Analysts downgraded ExxonMobil from Buy to Hold ahead of Q4 2025 earnings due to stretched valuation and limited near-term upside. Despite progress in molecule management, carbon capture and lithium initiatives supporting long-term margin expansion, lower crude prices and minimal Q4 estimate revisions heighten near-term stock risk.